title: Association analysis between polymorphisms in the myo-inositol monophosphatase 2 (IMPA2) gene and bipolar disorder.
abstract: Linkage studies in bipolar disorder (BPD) suggest that a susceptibility locus exists on chromosome 18p11. The myo-inositol monophosphatase 2 gene (IMPA2) maps to this genomic region. Myo-inositol monophosphatase dephosphorylates inositol monophosphate, regenerating free inositol. Lithium, a common treatment for BPD, has been shown to inhibit IMPA2 activity and decrease levels of inositol. It is hypothesized that lithium conveys its therapeutic effect for BPD patients partially through inositol regulation. Hence, dysfunction of inositol caused by IMPA2 irregularity may contribute to the pathophysiology of BPD. In this study, we hypothesize that genetic variations in the IMPA2 gene contributes to increased susceptibility to BPD. We tested this hypothesis by genotyping 9 SNPs (rs1787984; rs585247; rs3974759; rs650727; rs589247; rs669838; rs636173; rs3786285; rs613993) in BPD patients (n=556) and controls (n=735). Genotype and allele frequencies were compared between groups using Chi square contingency analysis. Linkage disequilibrium (LD) between markers was calculated and estimated haplotype frequencies were compared between groups. Single marker analysis revealed several associations between IMPA2 variations and BPD, which were subsequently rendered non-significant after correction for multiple testing. Although our study did not show strong support for an association between the tested IMPA2 polymorphisms and susceptibility to BPD, additional larger studies are necessary to comprehensively investigate a role of the IMPA2 gene in the pathophysiology of BPD.
authors.affiliation: Psychiatric Pharmacogenetics Laboratory, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Bloch
authors.forename: Andrew E
authors.initials: AE
authors.lastname: Weller
authors.forename: Glenn A
authors.initials: GA
authors.lastname: Doyle
authors.forename: Thomas N
authors.initials: TN
authors.lastname: Ferraro
authors.forename: Wade H
authors.initials: WH
authors.lastname: Berrettini
authors.forename: Rachel
authors.initials: R
authors.lastname: Hodge
authors.forename: Falk W
authors.initials: FW
authors.lastname: Lohoff
mesh_terms: D000328:Adult; D001714:Bipolar Disorder / Q000175:diagnosis / Q000201:enzymology* / Q000235:genetics*; D005260:Female; D005819:Genetic Markers / Q000235:genetics; D055106:Genome-Wide Association Study / Q000379:methods; D006239:Haplotypes / Q000235:genetics; D006801:Humans; D008297:Male; D010744:Phosphoric Monoester Hydrolases / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*
chemical_list: D005819:Genetic Markers; D010744:Phosphoric Monoester Hydrolases; C021822:myo-inositol-1 (or 4)-monophosphatase
references.citation: J Neural Transm (Vienna). 2008 Sep;115(9):1339-45
references.pmid: 18665321
references.citation: Nat Rev Genet. 2007 Sep;8(9):657-62
references.pmid: 17703236
references.citation: Mol Psychiatry. 2009 Aug;14(8):755-63
references.pmid: 19488044
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5;141B(8):868-73
references.pmid: 16941653
references.citation: Eur J Hum Genet. 2004 May;12(5):395-9
references.pmid: 14872201
references.citation: Psychiatr Genet. 1998 Winter;8(4):235-8
references.pmid: 9861642
references.citation: Mol Psychiatry. 2008 Jun;13(6):558-69
references.pmid: 18317468
references.citation: Int J Neuropsychopharmacol. 2009 Feb;12(1):33-43
references.pmid: 18771604
references.citation: Biochem Biophys Res Commun. 2004 Nov 26;324(4):1370-8
references.pmid: 15504365
references.citation: Bioinformatics. 2005 Jan 15;21(2):263-5
references.pmid: 15297300
references.citation: Am J Epidemiol. 2003 Sep 1;158(5):397-400
references.pmid: 12936892
references.citation: Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):5918-21
references.pmid: 8016089
references.citation: Mol Psychiatry. 2000 Jul;5(4):389-95
references.pmid: 10889549
references.citation: Am J Med Genet. 1997 May 31;74(3):227-37
references.pmid: 9184304
references.citation: Proc Natl Acad Sci U S A. 1999 May 11;96(10):5604-9
references.pmid: 10318931
references.citation: Mol Psychiatry. 2007 Nov;12(11):1033-41
references.pmid: 17440433
references.citation: Ann Hum Genet. 2001 Mar;65(Pt 2):207-19
references.pmid: 11427179
references.citation: Mol Psychiatry. 1999 Jan;4(1):76-84
references.pmid: 10089014
references.citation: J Biol Chem. 2005 Mar 11;280(10):9106-18
references.pmid: 15611057
references.citation: Mol Psychiatry. 2005 Nov;10(11):1017-25
references.pmid: 16044173
references.citation: Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13060-5
references.pmid: 8917544
references.citation: Mol Psychiatry. 2002;7(4):337-9
references.pmid: 11986976
references.citation: Mol Psychiatry. 1997 Sep;2(5):393-7
references.pmid: 9322233
references.citation: Arch Gen Psychiatry. 2004 Mar;61(3):300-8
references.pmid: 14993118
references.citation: Cell. 1989 Nov 3;59(3):411-9
references.pmid: 2553271
references.citation: Mol Psychiatry. 2008 Feb;13(2):197-207
references.pmid: 17486107
references.citation: Psychiatr Genet. 2005 Dec;15(4):255-8
references.pmid: 16314755
references.citation: Int J Methods Psychiatr Res. 2004;13(2):93-121
references.pmid: 15297906
references.citation: Arch Gen Psychiatry. 1994 Nov;51(11):849-59; discussion 863-4
references.pmid: 7944874
references.citation: Am J Hum Genet. 1998 Nov;63(5):1531-40
references.pmid: 9867708
references.citation: Mol Psychiatry. 2005 Oct;10(10):900-19
references.pmid: 16027739
references.citation: J Neural Transm (Vienna). 2001;108(7):849-54
references.pmid: 11515750
references.citation: Nat Genet. 2004 Apr;36(4):388-93
references.pmid: 15052270
references.citation: Am J Med Genet. 1996 Sep 20;67(5):491-4
references.pmid: 8886169
references.citation: Theor Popul Biol. 2001 Nov;60(3):227-37
references.pmid: 11855957
references.citation: Am J Hum Genet. 1995 Dec;57(6):1384-94
references.pmid: 8533768
references.citation: Biol Psychiatry. 2004 Oct 1;56(7):483-9
references.pmid: 15450783
references.citation: Am J Med Genet. 1999 Oct 15;88(5):503-9
references.pmid: 10490707
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2003 Jul 1;120B(1):72-8
references.pmid: 12815743
references.citation: Neuropsychopharmacology. 2007 Aug;32(8):1727-37
references.pmid: 17251911
references.citation: Biometrics. 1999 Dec;55(4):997-1004
references.pmid: 11315092
references.citation: Nature. 2007 Jun 7;447(7145):661-78
references.pmid: 17554300
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2010 Apr 5;153B(3):830-6
references.pmid: 19859903
references.citation: Mol Psychiatry. 2004 Jun;9(6):621-9
references.pmid: 14699425
references.citation: Mol Psychiatry. 2002;7(2):189-200
references.pmid: 11840312
references.citation: Psychiatr Genet. 2006 Feb;16(1):3-8
references.pmid: 16395123
references.citation: Mol Psychiatry. 1997 Oct-Nov;2(6):501-4
references.pmid: 9399696
references.citation: Biochem Soc Trans. 2009 Oct;37(Pt 5):1099-103
references.pmid: 19754460
references.citation: Mol Psychiatry. 2000 Mar;5(2):165-71
references.pmid: 10822344
references.citation: Am J Epidemiol. 2002 Mar 1;155(5):478-84
references.pmid: 11867360
references.citation: Am J Hum Genet. 1996 Nov;59(5):983-9
references.pmid: 8900224
references.citation: Am J Hum Genet. 2000 Jun;66(6):1933-44
references.pmid: 10801388